title: FVII, FVIIa, and downstream markers of extrinsic pathway activation differ by EPCR Ser219Gly variant in healthy men.
abstract: OBJECTIVE
  The purpose of this study was to determine the effect of a variant in EPCR (Ser219Gly), previously shown to affect EPCR shedding, on plasma FVII, FVIIa, and downstream markers of activated coagulation.
  
  
  RESULTS
  Statistical analysis was undertaken in approximately 2000 healthy middle aged men (NPHSII). Higher soluble EPCR levels were confirmed for Gly allele carriers (P<0.0001). Significantly higher levels of FVII, FVIIa, and downstream markers of activated coagulation in the extrinsic pathway (FIX activation pep [FIXpep]; FX activation pep [FXpep]), and prothrombin F1+2 (F1+2) were identified in baseline samples, in Gly carriers compared to Ser/Ser (P<or=0.04 for trend). In repeat samples collected for up to 5 years, levels of FVII and F1+2 were higher in Gly allele carriers compared to Ser/Ser by (FVII: 6.9% CI 5.5 to 8.4 in Ser/Gly; and 23.4% CI 16.3 to 30.8 in Gly/Gly, P<0.0001), (F1+2: 8.1% CI 5.2 to 11.1 in Ser/Gly; 25.2% CI 11.8 to 40.3 in Gly/Gly, P<0.04), confirming reproducibility of findings at baseline. Molar ratios for FIXpep, FXpep, and F1+2 to FVIIa were constant in Ser/Ser and Ser/Gly but tended to be higher in Gly/Gly, reaching statistical significance for FIXpep:FVIIa (P=0.04).
  
  
  CONCLUSIONS
  These data suggest that higher levels of FVII and FVIIa circulate when EPCR shedding is greatest. Furthermore, these results suggest consequences for activation of extrinsic coagulation.
authors.affiliation: Centre for Cardiovascular Genetics, Division of Medicine, University College London, UK. h.ireland@ucl.ac.uk
authors.forename: Helen A
authors.initials: HA
authors.lastname: Ireland
authors.forename: Jackie A
authors.initials: JA
authors.lastname: Cooper
authors.forename: Fotios
authors.initials: F
authors.lastname: Drenos
authors.forename: Jayshree
authors.initials: J
authors.lastname: Acharya
authors.forename: Jacqueline P
authors.initials: JP
authors.lastname: Mitchell
authors.forename: Ken A
authors.initials: KA
authors.lastname: Bauer
authors.forename: James H
authors.initials: JH
authors.lastname: Morrissey
authors.forename: M Peter
authors.initials: MP
authors.lastname: Esnouf
authors.forename: Stephen E
authors.initials: SE
authors.lastname: Humphries
mesh_terms: D015703:Antigens, CD / Q000378:metabolism*; D001777:Blood Coagulation / Q000235:genetics* / Q000502:physiology; D015331:Cohort Studies; D000074283:Endothelial Protein C Receptor; D004797:Enzyme-Linked Immunosorbent Assay; D005167:Factor VII / Q000378:metabolism*; D015942:Factor VIIa / Q000378:metabolism*; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D005838:Genotype; D006579:Heterozygote; D006801:Humans; D008297:Male; D054526:Men's Health; D008875:Middle Aged; D011446:Prospective Studies; D011956:Receptors, Cell Surface / Q000378:metabolism*; D012016:Reference Values
chemical_list: D015703:Antigens, CD; D000074283:Endothelial Protein C Receptor; D005819:Genetic Markers; C478370:PROCR protein, human; D011956:Receptors, Cell Surface; D005167:Factor VII; D015942:Factor VIIa
references.citation: Circulation. 2000 Dec 5;102(23):2816-22
references.pmid: 11104738
references.citation: J Immunoassay. 1996 May;17(2):119-31
references.pmid: 8744282
references.citation: J Biol Chem. 2000 Feb 25;275(8):5447-52
references.pmid: 10681521
references.citation: J Biol Chem. 2006 Sep 29;281(39):28850-7
references.pmid: 16867987
references.citation: Semin Thromb Hemost. 2006 Apr;32 Suppl 1:49-60
references.pmid: 16673266
references.citation: Blood. 2008 Apr 1;111(7):3442-51
references.pmid: 18073349
references.citation: Atherosclerosis. 2005 Dec;183(2):283-92
references.pmid: 15921688
references.citation: Thromb Haemost. 1995 Jan;73(1):82-6
references.pmid: 7740501
references.citation: J Biol Chem. 2007 Apr 20;282(16):11849-57
references.pmid: 17327234
references.citation: J Thromb Haemost. 2004 Aug;2(8):1305-10
references.pmid: 15304035
references.citation: J Thromb Haemost. 2007 Sep;5(9):1817-24
references.pmid: 17723119
references.citation: Blood. 1990 Aug 15;76(4):731-6
references.pmid: 2383653
references.citation: Blood. 1989 Nov 1;74(6):2007-15
references.pmid: 2804345
references.citation: Thromb Haemost. 2004 May;91(5):905-11
references.pmid: 15116250
references.citation: J Thromb Haemost. 2008 Feb;6(2):259-67
references.pmid: 17973650
references.citation: Biochemistry. 1996 Feb 13;35(6):1904-10
references.pmid: 8639673
references.citation: Blood. 2004 Feb 15;103(4):1311-8
references.pmid: 14576048
references.citation: Blood. 1993 Feb 1;81(3):734-44
references.pmid: 8427965
references.citation: Blood. 1982 May;59(5):1086-97
references.pmid: 7074214
references.citation: J Thromb Haemost. 2006 Jan;4(1):229-35
references.pmid: 16409473
references.citation: Blood. 2007 Feb 1;109(3):1003-9
references.pmid: 17023579